Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BONO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.783
EU - Europa 1.102
AS - Asia 863
SA - Sud America 191
AF - Africa 25
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.747
IT - Italia 458
SG - Singapore 378
DE - Germania 214
CN - Cina 209
BR - Brasile 163
HK - Hong Kong 99
RU - Federazione Russa 93
FI - Finlandia 88
GB - Regno Unito 48
PL - Polonia 43
FR - Francia 41
IN - India 37
VN - Vietnam 34
NL - Olanda 26
SE - Svezia 21
CA - Canada 18
MX - Messico 14
RO - Romania 13
TR - Turchia 13
KR - Corea 12
AT - Austria 11
BD - Bangladesh 11
IE - Irlanda 11
IR - Iran 9
PK - Pakistan 9
EC - Ecuador 7
IQ - Iraq 7
ZA - Sudafrica 7
BE - Belgio 6
EG - Egitto 6
ES - Italia 6
JP - Giappone 6
MY - Malesia 6
AR - Argentina 5
CI - Costa d'Avorio 5
ID - Indonesia 4
LT - Lituania 4
SA - Arabia Saudita 4
UA - Ucraina 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
KE - Kenya 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
GR - Grecia 2
KG - Kirghizistan 2
MA - Marocco 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
PT - Portogallo 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
PH - Filippine 1
SI - Slovenia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.968
Salva come PNG Salva come JPEG
Città #
Ashburn 346
Singapore 184
Chandler 155
Fairfield 147
Palermo 104
Hong Kong 93
Munich 92
The Dalles 77
Woodbridge 77
Rome 72
Helsinki 67
Wilmington 61
Houston 59
Beijing 56
Seattle 53
New York 43
Cambridge 40
Moscow 39
Dallas 33
Hefei 33
Los Angeles 31
Medford 31
Zgierz 31
Ann Arbor 30
Des Moines 28
Frankfurt am Main 28
Chicago 23
Santa Clara 20
Buffalo 19
Princeton 18
Bremen 16
São Paulo 16
San Diego 14
Lawrence 13
Ludwigshafen am Rhein 13
Ho Chi Minh City 12
Seoul 12
Kitzingen 11
Orem 11
Dublin 10
Lappeenranta 10
London 10
Nuremberg 10
Council Bluffs 9
Milan 9
Naples 9
Warsaw 9
Boardman 8
Brooklyn 8
Kumar 8
Pune 8
Altamura 7
Aversa 7
Hanoi 7
Monza 7
Phoenix 7
Redwood City 7
Tappahannock 7
Turin 7
Atlanta 6
Bexley 6
Brussels 6
Denver 6
Jinan 6
Johannesburg 6
Messina 6
Montreal 6
Mumbai 6
Rio de Janeiro 6
Salt Lake City 6
Tokyo 6
Venice 6
Abidjan 5
Boston 5
Cairo 5
Chennai 5
Manchester 5
Mexico City 5
Redondo Beach 5
Stockholm 5
Volla 5
Cagliari 4
Catania 4
Changsha 4
Falkenstein 4
Hebei 4
Jyväskylä 4
Ottawa 4
Querétaro 4
Quito 4
Rawalpindi 4
Ribeirão Preto 4
Roubaix 4
San Francisco 4
Shenyang 4
Toronto 4
Ankara 3
Baku 3
Bauru 3
Belo Horizonte 3
Totale 2.567
Salva come PNG Salva come JPEG
Nome #
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 270
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 239
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 188
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 180
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 178
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 168
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 163
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 163
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 161
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 159
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 158
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 144
Multigene panel testing in Hereditary Breast and Ovarian Cancer: an effective liquid biopsy approach to identify mutations in genes involved in the Homologous Recombination pathway 144
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 139
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 123
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 116
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 115
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 114
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 113
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 112
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 110
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 107
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 102
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 100
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 87
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 81
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 81
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 80
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 79
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 75
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 71
Scientific Communication and oncology – "The bridge between knowledge and patients" 63
null 25
Totale 4.208
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021243 0 0 0 0 0 39 9 42 43 48 22 40
2021/2022303 29 49 9 18 8 24 10 23 28 34 23 48
2022/2023450 41 61 13 64 38 62 36 43 53 6 16 17
2023/2024341 13 31 22 36 28 63 62 14 7 12 8 45
2024/20251.185 36 51 61 58 56 88 190 112 73 152 157 151
2025/20261.231 262 123 178 256 285 127 0 0 0 0 0 0
Totale 4.208